Vakrangee, Sandhar Technologies and Natco Pharma to see some action today

Vakrangee (VL) has tied up with Nayara Energy for setting up Vakrangee Kendra outlets at its Nayara retail fuel outlets. Nayara Energy is a privately-held downstream oil company based in Mumbai, India, that encompasses refining, marketing, production and a network of over 6,000+ retail fuel outlets in India. It operates India's second-largest oil refinery in Vadinar, Gujarat.

Sandhar Technologies has acquired/purchased 1,48,23,143 equity shares (i.e. 47.82% of total shareholding) of Sandhar Daewha Automotive Systems on December 28, 2021. The shareholding of the Company has increased from 52.18% to 100% of the total shareholding in Sandhar Daewha Automotive Systems Private (SDASPL), accordingly SDASPL has become the Wholly Owned Subsidiary of the Company.

Natco Pharma has received approval for Covid 19 drug Molnupiravir Capsules 200 mg. for Indian market, which will be sold under brand name MOLNUNAT. Molnupiravir is the first Covid drug authorized by Drugs Controller General (India) (DCGI) for the treatment of Covid 19 infection with Sp02>93% and who have high risk of progression of the disease including hospitalization or death. This capsule was earlier approved in United Kingdom and United States of America.

ICICI Prudential Life Insurance Company has launched new term plan offering 105% return of the premium paid at age of 60 or 70 or on policy maturity as the policy auto-adjusts the life cover based on the changing life-stages of the insured. The new policy, ICICI Pru iProtect return of premium, also offers an option to take cover against 64 critical illnesses.

Strides Pharma Science has received Emergency Use Authorization (EUA) from the Drugs Controller General of India (DCGI) to launch Molnupiravir 200mg in India.  Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS?CoV?2 and the clinical studies have shown this drug to be active against the most common Covid?19 variants.  

Visaka Industries has been granted a patent for its product ‘ATUM’ Solar Roof by the United States of America Patent Office, which is valid for 20 years. The patent has been granted for the invention titled ‘Eco-Friendly Energy Generating Roofs.’ ATUM is categorized as a ‘MAKE IN INDIA’ product as all its component parts are developed, manufactured, and assembled in India. ATUM is a roof that generates electricity. It is the world’s first completely integrated, seamless solar roof made with MONO Crystalline PERC cells which makes it 50% more efficient than traditional solar panels.

Sun Pharmaceutical Industries’ wholly-owned subsidiary has received Emergency Use Authorization (EUA) from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of MSD (a trade name of Merck & Co., Inc, Kenilworth, NJ, USA) and Ridgeback’s molnupiravir under the brand name Molxvir in India.